A detailed history of Alliancebernstein L.P. transactions in Evolus, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 62,440 shares of EOLS stock, worth $732,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,440
Previous 62,440 -0.0%
Holding current value
$732,421
Previous $677,000 49.34%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$9.99 - $14.91 $39,560 - $59,043
3,960 Added 6.77%
62,440 $874,000
Q4 2023

Feb 14, 2024

SELL
$7.6 - $10.53 $50,008 - $69,287
-6,580 Reduced 10.11%
58,480 $615,000
Q3 2023

Nov 14, 2023

BUY
$7.15 - $10.2 $715 - $1,019
100 Added 0.15%
65,060 $594,000
Q2 2023

Aug 15, 2023

BUY
$7.23 - $10.52 $95,146 - $138,443
13,160 Added 25.41%
64,960 $472,000
Q4 2022

Feb 14, 2023

BUY
$6.52 - $8.95 $24,776 - $34,010
3,800 Added 7.92%
51,800 $389,000
Q3 2022

Nov 15, 2022

SELL
$7.76 - $13.72 $277,846 - $491,244
-35,805 Reduced 42.72%
48,000 $386,000
Q2 2022

Aug 15, 2022

BUY
$10.22 - $13.94 $418,049 - $570,215
40,905 Added 95.35%
83,805 $972,000
Q1 2022

May 13, 2022

BUY
$5.22 - $11.78 $1,044 - $2,356
200 Added 0.47%
42,900 $481,000
Q2 2021

Jul 30, 2021

BUY
$8.42 - $13.96 $44,626 - $73,988
5,300 Added 14.17%
42,700 $540,000
Q1 2021

May 06, 2021

SELL
$3.2 - $16.51 $88,320 - $455,676
-27,600 Reduced 42.46%
37,400 $486,000
Q3 2020

Nov 12, 2020

SELL
$3.03 - $5.48 $3,333 - $6,028
-1,100 Reduced 1.66%
65,000 $254,000
Q2 2020

Aug 13, 2020

BUY
$3.53 - $6.17 $35,300 - $61,700
10,000 Added 17.83%
66,100 $350,000
Q1 2020

May 14, 2020

BUY
$3.53 - $12.21 $57,892 - $200,244
16,400 Added 41.31%
56,100 $233,000
Q3 2019

Nov 14, 2019

BUY
$13.91 - $19.87 $80,678 - $115,246
5,800 Added 17.11%
39,700 $620,000
Q2 2019

Aug 14, 2019

BUY
$13.19 - $28.36 $114,753 - $246,732
8,700 Added 34.52%
33,900 $496,000
Q1 2019

May 14, 2019

SELL
$12.43 - $28.91 $52,206 - $121,422
-4,200 Reduced 14.29%
25,200 $569,000
Q4 2018

Feb 13, 2019

BUY
$10.57 - $19.29 $76,104 - $138,888
7,200 Added 32.43%
29,400 $350,000
Q3 2018

Nov 08, 2018

BUY
$17.31 - $29.82 $76,164 - $131,208
4,400 Added 24.72%
22,200 $413,000
Q2 2018

Aug 13, 2018

BUY
$6.85 - $38.49 $121,930 - $685,122
17,800 New
17,800 $498,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $658M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.